. . . .which is why this sort of e-mail traffic is so unfortunate -- here, the Lead Medical Investigator of the ENHANCE study (Dr. Kastelein) is trying to get a meeting scheduled with Schering-Plough and Merck executives, to go through ENHANCE issues, and apparently, the ball has been dropped on scheduling the meeting -- things aren't progressing. So, one of the Merck (Schering's partner) executives asks about the "level of priority" on the project, at the Schering-Plough Research Institute (or "SPRI", below) -- remember, this is about a year and a half after the study was completed. Profanity ensues. As ever, click to enlarge:
This sort of traffic might lead one to wonder whether SPRI executives had some "additional motivation" in not promptly following-up on these presumably-proper requests -- from the study's lead medical investigator, no less -- to schedule an important meeting.
Saturday, April 12, 2008
The vast majority of Schering employees are decent, honest, hard-working people. . . .
Subscribe to:
Post Comments (Atom)
7 comments:
I've used your "small print" on my blog - hope this is ok. Let me know if not.
Cheers
My pleasure.
No problem.
I posted the link to your blog on the cafepharma SP board. Was it you who replied, or someone pretending to be you?
It WAS me. Thanks for the link!
-- rainnn
The prick referred to isn't another Schering executive. It is a Merck executive.
I see. That makes it. . . .um, okay?
Wild.
Once, at 4:06 am? Smile…
Post a Comment